ACA
Arcosa, Inc. (ACA) Risks & Opportunities Analysis (2026)
Risks
ACA’s leverage is moderate with net debt/EBITDA at 1.7x and interest coverage above 3x, limiting refinancing risk versus more levered peers but leaving less cushion if spreads widen.
A 98.6-day cash conversion cycle and 74.3 days of receivables indicate working-capital drag, which can pressure cash generation more than faster-turning peers in the same distribution model.
Current and quick ratios above 3.0x and 2.3x respectively reduce near-term liquidity risk, but they also imply capital is tied up in operating assets versus leaner peers.
The absence of disclosed TTM free-cash-flow margin in the provided metrics limits visibility on cash conversion quality, which can weigh on valuation versus peers with clearer cash generation disclosure.
Opportunities
ACA’s strong liquidity profile, with a 3.1x current ratio and 2.3x quick ratio, supports operating flexibility versus peers that must preserve cash more aggressively.
Moderate leverage at 1.7x net debt/EBITDA gives ACA room to absorb demand volatility or fund growth initiatives more comfortably than higher-debt peers.
Interest coverage of 3.3x suggests debt service is manageable, which can preserve strategic optionality relative to peers facing tighter covenant or refinancing constraints.
If working-capital intensity normalizes from the current 98.6-day cash conversion cycle, ACA could convert more earnings into cash than peers with structurally slower collections.
Overall Score
ACA’s forward positioning is supported by solid liquidity and manageable leverage, while working-capital intensity and only moderate interest coverage remain the main constraints versus peers.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Arcosa, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

